ArticleBone & joint open2025
Rate and predictors of relapse and surgery in idiopathic clubfeet after successful Ponseti treatment in infancy : a single centre, retrospective, comparative study.
Article in Bone & joint open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Global prevalence, patterns, and predictors of relapse following Ponseti treatment for idiopathic clubfoot: a systematic review and meta-analysis.BMC musculoskeletal disorders · 2026Pooled it
- Article
- Contemporary national treatment patterns for clubfoot relapse-related interventions: a large multi-institutional cohort.BMC musculoskeletal disorders · 2026Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aims: To assess the rates of relapse and risk factors for release and surgical intervention in patients with idiopathic clubfoot. Methods: A retrospective review of all patients with idiopathic clubfoot and initiation of Ponseti treatment between February 2005 and December 2015 was conducted. All patients with successful initial Ponseti casting treatment at the study institution and one year of follow-up were included. Rates of relapse, surgery, and types of surgical procedures performed were collected. Results: The final cohort included 268 children with 397 idiopathic clubfeet, consisting of 98 females (36.6%) and 170 males (63.4%). The successfully Ponseti-treated group without relapse was composed of 171 children with 252 feet (63.5% of total cohort). A total of 97 patients (36.2%) had a relapse and required further intervention (relapse group). There was a greater proportion of patients with complex-type clubfoot in the relapse group (18.6% vs 4.7%, p = 0.001). Patients who never relapsed presented at a median age of 33.7 days (IQR 40.8), while those who relapsed presented at a significantly younger age, at a median of 25.1 days (IQR 17.2) (p < 0.001). Children in the no-relapse group required significantly fewer casts to achieve correction, with a mean of 4.3 compared with 5.2 in patients with relapse (p < 0.001). Children in the no-relapse group showed a significantly higher rate of good adherence compared with those in the relapse-group (94.9% vs 62.3%, p < 0.001). In total, 24 children (23 feet, 5.8% of total cohort) underwent surgery, whereas 74 had a relapse but did not require surgery. The most common surgical procedures performed were tibialis anterior tendon transfer (n = 25) and open tendoachilles lengthening (n = 21). Conclusion: We confirm that a higher number of casts to achieve correction in the initial Ponseti series, younger age at presentation, complex clubfoot features, and poor brace adherence may be correlated with risk of relapse and surgery. The need for joint invasive surgery is rarely indicated.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.